Rejuvenate Biomed’s clinical trial demonstrates the therapeutic potential of RJx-01 in sarcopenia

Cutting-edge therapy shows meaningful improvements in muscle strength, function and fatigue resistance, offering hope for millions suffering from sarcopenia DIEPENBEEK, Belgium, Feb. 21, 2024 /PRNewswire/ — Rejuvenate Biomed NV (“Rejuvenate Biomed”), a pioneering clinical-stage platform…